PubRank

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMID 25187524)

Published in Eur Heart J on September 03, 2014

Authors

Thomas Vanassche1, Mandy N Lauw2, John W Eikelboom2, Jeff S Healey2, Robert G Hart2, Marco Alings3, Alvaro Avezum4, Rafael Díaz5, Stefan H Hohnloser6, Basil S Lewis7, Olga Shestakovska2, Jia Wang2, Stuart J Connolly2

Author Affiliations

1: Population Health Research Institute, McMaster University and Hamilton Health Sciences, 237 Barton St. E., Hamilton, ON, Canada L8L 2X2 thomas.vanassche@phri.ca.
2: Population Health Research Institute, McMaster University and Hamilton Health Sciences, 237 Barton St. E., Hamilton, ON, Canada L8L 2X2.
3: Amphia Ziekenhuis, Breda, The Netherlands.
4: Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.
5: Estudios Clinícos Latinoamérica, Rosario, Argentina.
6: Department of Cardiology, Johann-Wolfgang-Goethe-Universität, Frankfurt, Germany.
7: Cardiovascular Clinical Research Institute, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-IIT, Haifa, Israel.

Articles citing this ↘

Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model. Stroke (2016) 0.87

Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial. Trials (2015) 0.81

How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices. J Stroke (2016) 0.81

Clinical Differences between Subtypes of Atrial Fibrillation and Flutter: Cross-Sectional Registry of 407 Patients. Arq Bras Cardiol (2015) 0.79

Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey. Sci Rep (2016) 0.78

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J (2017) 0.77

Nonsustained Atrial Fibrillation in Ischemic Stroke Patients and Stroke-Free Controls From the Perspective of Stroke Pathophysiology. J Am Heart Assoc (2016) 0.76

Cardioembolic Stroke. Circ Res (2017) 0.75

Does atrial fibrillation pattern affect stroke risk? Data dredging to help the clinician. Eur Heart J (2014) 0.75

Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) (2015) 0.75

Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention. F1000Res (2016) 0.75

Cost Effectiveness of Implantable Cardiac Monitor-Guided Intermittent Anticoagulation for Atrial Fibrillation: An Analysis of the REACT.COM Pilot Study. J Cardiovasc Electrophysiol (2016) 0.75

Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy. Nat Rev Cardiol (2016) 0.75

New-Onset Atrial Fibrillation in the Critically Ill. Crit Care Med (2017) 0.75

Presence of diabetic microvascular complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation: A nationwide cohort study. Medicine (Baltimore) (2016) 0.75

Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nat Rev Cardiol (2017) 0.75

Articles by these authors ⇆

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. Eur Heart J (2017) 0.83